Liquid Tamiflu hits FDA shortage list; India nixes new controls on foreign pharma deals; Impax and Durect ink a deal;

@FiercePharma: Dean Hart, ex-Takeda VP sales, joins consulting firm Delta Point. Release | Follow @FiercePharma

@TracyStaton: Most-read report at FiercePharma Tuesday: Top 10 Drug Patent Losses of 2014. More from FiercePharma | Follow @TracyStaton

@EricPFierce: Put FiercePharma in your pocket. Get the mobile app for iOS or Android here, fiercepharma.com/mobile | Follow @EricPFierce

@CarlyHFierce: Welcome to our newest addition to the Fierce Life Sciences team, associate editor Emily Wasserman! You can find her at @EmilyWFierce. | Follow @CarlyHFierce

> The oral liquid form of Roche's ($RHHBY) flu fighter, Tamiflu, often used for children, is running scarce, the FDA says; supplies are expected to return to normal mid-month. Report

> India has decided against capping foreign investment in "critical" areas of the pharma industry, allowing multinational companies to continue buying controlling stakes in Indian drugmakers, subject to regulatory review. Report

> Impax Laboratories ($IPXL) and Durect ($DRRX) inked a deal to resurrect the latter's patch for shingles pain, Eladur; the companies will co-develop and commercialize the product. Release

> Chapel Hill, NC-based G1 Therapeutics recruited former Johnson & Johnson ($JNJ) executive Seth Rudnick to join its board. Report

> Methamphetamine seized in a recent Chinese drug bust was made using GlaxoSmithKline's ($GSK) popular cold medicine, Contac, officials said; GSK said it is "very concerned" by diversion of its drugs for illicit purposes. Report

Medical Device News

@FierceMedDev: India's Forus hauls in $8M for portable eye-screening device. More | Follow @FierceMedDev

@MichaelGFierce: Durect, Impax tie up for a shingles patch to last 6 times as long as Lidoderm. More from FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: FiercePharma has gone mobile! Check out the new app here. | Follow @EmilyWFierce

@GalenMoore: Former Hologic CEO Cascella lands at rival DySIS. Story | Follow @GalenMoore

> Foundation Medicine teams up with Novartis for cancer diagnostics. Item

> ArthroCare will pay $30M to finally settle up with the feds. Story

> Analysts have high hopes for St. Jude in 2014. Article

Biotech News

@FierceBiotech: AbbVie adds a slate of $280M wagers on Seattle Genetics' "armed" antibody cancer tech. News | Follow @FierceBiotech

@JohnCFierce: Another SGLT2 drug arrives. Farxiga (dapagliflozin) from AZ. Release | Follow @JohnCFierce

@DamianFierce: Friendly reminder that there were 27 drugs approved last year and we wrote, like, 1,000 words on each. Report | Follow @DamianFierce

@EmilyMFierce: AstraZeneca has made 3 deals in past 5 days. Today with Immunocore: Story. Yesterday was Horizon: News. | Follow @EmilyMFierce

> Ironwood focuses on sales, sacrifices R&D in restructuring. More

> $25M Series B helps Blueprint Medicines pursue individualized cancer therapies. Story

> Catalyst boosted as 'breakthrough' PhIII drug clears safety hurdle. Article

Drug Delivery News

> Gene delivery method 'hijacks' tumor blood vessels. More

> How a single nanoparticle delivers two drugs separately to kill cancer cells. Story

> Durect, Impax tie up for a shingles patch to last 6 times as long as Lidoderm. Article

> Vaccine nanoparticles offer shake-and-bake field delivery. Report

> Armed with cancer drugs, white blood cells become cancer-killing sticky bombs. News

> India to require all changes in delivery to be regulated as a new drug. Item

Diagnostics News

> Metabolon names two new investors in its $15M Series E. More

> Foundation Medicine deepens its Novartis ties with new deal. News

> Maverix Biomics hauls in $6M for gene sequencing software. Item

> The market for noninvasive prenatal tests could triple by 2019, analysts say. Story

> Kindstar partners with Israeli BioView to bring lung cancer Dx to Asia. Report

> SRI bags $4.5M NIH contract to set up metabolomics outpost. Article

And Finally... Developing shingles, a painful skin condition caused by the chickenpox virus, can increase one's risk of heart attack. Report

Suggested Articles

Former Indivior CEO Shaun Thaxter will face six months in federal prison for his role in misleading government officials on the dangers of Suboxone.

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.